Emergen-C
An American vitamin supplement brand best known for powdered vitamin C drink mixes that dissolve in water.
Last updated August 21, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Emergen-C is an American dietary-supplement brand centered on effervescent powdered drink mixes containing vitamin C and, depending on the formulation, B vitamins and other nutrients. Consumers typically dissolve the powder in water, making the product a beverage-like alternative to tablets, capsules, and conventional vitamin drinks. The brand is especially associated with immune-support positioning, portability, and single-serving sachets sold through supermarkets, pharmacies, health retailers, and online channels. The product line was introduced in 1978 by Alacer Corp., a private company established in 1972 with a focus on vitamin C supplements. Emergen-C helped make powdered vitamin supplementation a recognizable consumer format by combining a flavored drink experience with a high stated level of vitamin C. Product varieties differ, but reference material describes some formulations as providing multiple times the USDA Reference Daily Intake for vitamin C, vitamin B6, and vitamin B12. Other versions have included ingredients such as calcium, glucosamine, quercetin, or lycopene. Emergen-C has been marketed as a convenient product for everyday wellness and immune support rather than as a conventional pharmaceutical treatment. That positioning has also created regulatory and litigation risk when advertising or packaging could be understood as claiming that the product prevents colds or flu. In 2013, a California class-action settlement involving Alacer received preliminary approval over allegations that health-benefit representations lacked adequate scientific support; final approval followed in 2014. The settlement did not represent an admission of wrongdoing by the company. The brand's corporate ownership changed as the consumer-health industry consolidated. Alacer was acquired by Pfizer in 2012. Pfizer's consumer-health business subsequently entered a joint venture with GlaxoSmithKline in 2019, and the resulting consumer-health portfolio became part of Haleon when that company separated from GSK and began operating independently in July 2022. Emergen-C therefore moved from an independent supplement company to a major multinational consumer-health portfolio while retaining its established product identity. Manufacturing has also evolved. GSK advanced plans to close a plant in Carlisle, Pennsylvania, with production of Emergen-C powdered drink-mix products intended to move to a facility in Puerto Rico. The transition illustrated the brand's integration into a broader international supply chain. Ingredient information has varied by product: Alacer stated that it sought non-GMO materials where possible but did not guarantee that every raw material was non-GMO. Most products were described as free of animal-derived ingredients, although particular varieties could contain bovine chondroitin, honey, or vitamin D3 sourced from wool. In addition to commercial activity, Emergen-C has supported charitable initiatives. Alacer established the Emergen-C Fund in 1997, which reference material says raised more than $650,000 for organizations including Vitamin Angels, the Surfrider Foundation, Keep A Breast Foundation, the Young Survival Coalition, and Whole Planet Foundation. The brand also sponsored Operation Gratitude. In 2008, it collaborated with surf artist Jay Alders on packaging for Emergen-C Blue, with a donation to the Surfrider Foundation tied to each box sold. Today, Emergen-C remains an active supplement brand within Haleon's consumer-health portfolio, with its core identity still built around flavored vitamin C drink mixes and adjacent wellness formulations.
History
Emergen-C developed from Alacer Corp., a private supplement company established in 1972 with a focus on vitamin C products. Alacer introduced the Emergen-C line in 1978. Its central innovation was not a new vitamin ingredient but a consumer-friendly delivery format: flavored powder packaged for dissolution in water, producing an effervescent drink. This format connected nutritional supplementation with the convenience and sensory appeal of a beverage. The brand became associated with high-dose vitamin C and later with B vitamins and additional nutrients. Depending on the product, formulations could include calcium, glucosamine, quercetin, or lycopene. Marketing generally emphasized everyday wellness, energy, and immune support. Because these claims could overlap with representations about illness prevention or treatment, the brand later faced scrutiny over whether some marketing statements were supported by sufficient evidence. Alacer's ownership changed during the consolidation of the consumer-health sector. Pfizer acquired Alacer in 2012, moving Emergen-C from an independent supplement business into a large pharmaceutical company's consumer-health operations. Around the same period, production planning changed: reports described plans to close a GSK manufacturing site in Carlisle, Pennsylvania, and transfer Emergen-C powdered drink-mix production to Puerto Rico. The manufacturing decision reflected the restructuring of consumer-health supply chains rather than a change to the brand's basic product concept. In 2013, consumers filed a class action in California alleging that Alacer had deceptively marketed Emergen-C by suggesting that the supplement could reduce the risk of or prevent colds and flu without adequate scientific support. A judge preliminarily approved a $6.45 million settlement in December 2013, and final approval was granted in June 2014. The case became an important episode in the brand's history because it highlighted the distinction between general wellness messaging and disease-related claims. The settlement provided for refunds to eligible class members under stated conditions. Emergen-C also built a public profile through charitable and cause-related activity. Alacer established the Emergen-C Fund in 1997. Reference material reports that the fund raised more than $650,000 for groups including Vitamin Angels, the Surfrider Foundation, Keep A Breast Foundation, the Young Survival Coalition, and Whole Planet Foundation. The brand supported Operation Gratitude, which distributed care packages to U.S. troops in Iraq and Afghanistan. In 2008, Emergen-C worked with surf artist Jay Alders on packaging for the Emergen-C Blue flavor, linking product sales to a donation of 25 cents per box to the Surfrider Foundation. In 2019, Pfizer's consumer-health business entered a joint venture with GSK. Emergen-C subsequently became part of Haleon, the consumer-health company formed through the separation of GSK's consumer-health operations, with Haleon ownership beginning on 18 July 2022. The brand remains known primarily for single-serving vitamin C drink-mix sachets and related supplement varieties sold through mass retail, pharmacy, health, and digital channels. Product ingredient policies have included efforts to source non-GMO materials when possible, although Alacer stated that it could not guarantee that all raw materials were non-GMO. Animal-derived ingredients also varied by product, with some formulations containing bovine chondroitin, honey, or wool-derived vitamin D3.
- 2022
Brand transferred to Haleon
[1]Emergen-C became part of Haleon on 18 July 2022 following the separation of GSK's consumer-health business.
- 2019
Pfizer and GSK consumer-health joint venture
[1]Pfizer's consumer-health business entered a joint venture with GSK, affecting the corporate ownership structure around Emergen-C.
- 2014
Class-action settlement finalized
[1]A California court gave final approval to a settlement concerning alleged unsupported cold- and flu-prevention marketing claims.
- 2012
Alacer acquired by Pfizer
[1]Pfizer acquired Alacer and added Emergen-C to its consumer-health portfolio.
- 2008
Emergen-C Blue cause-marketing collaboration
[1]Emergen-C collaborated with surf artist Jay Alders on packaging for Emergen-C Blue and linked sales to donations for the Surfrider Foundation.
- 1997
Emergen-C Fund established
[1]Alacer established the Emergen-C Fund to support charitable and community organizations.
- 1978
Emergen-C introduced
[1]Alacer introduced the Emergen-C powdered effervescent vitamin supplement line.
- 1972
Alacer established
[1]Alacer Corp. was established as a private company focused on vitamin C supplements.
Products and positioning
Mass-market consumer health and wellness brand offering convenient, flavored powdered vitamin supplements, with a strong emphasis on vitamin C and immune-support occasions.
Vitamin C powdered supplement · 1978
Emergen-C Vitamin C Drink Mix
The core Emergen-C product is a flavored powder intended to be mixed with water. Formulations are built around vitamin C and commonly include B vitamins, with nutrient levels varying by variety. The product is packaged for convenient single-serving preparation and is marketed for everyday wellness and immune-support occasions.
Nutritional supplements
Emergen-C specialty formulations
The broader line has included versions with additional ingredients such as calcium, glucosamine, quercetin, or lycopene. These variants extend the brand beyond its basic vitamin C proposition while preserving the powdered, water-mixed delivery format. Exact availability and formulation depend on market and product version.
Flavored vitamin drink mix · 2008
Emergen-C Blue
Emergen-C Blue was a flavor and packaging initiative associated with a 2008 collaboration with surf artist Jay Alders. The launch connected the product with surf culture and a cause-marketing contribution to the Surfrider Foundation.
Controversies
2013
Class action over health-benefit marketing claims
A California class action alleged that Alacer marketed Emergen-C as reducing the risk of or preventing colds and flu without adequate scientific support. A judge preliminarily approved a $6.45 million settlement in December 2013; final approval followed in June 2014. The settlement provided a refund process for eligible consumers and was not described here as an admission of liability.
Marketing campaigns
- 2008Emergen-C Blue and Surfrider Foundation collaboration
United States
Emergen-C worked with surf artist Jay Alders to create packaging for Emergen-C Blue. The campaign pledged 25 cents to the Surfrider Foundation for every box sold.
Outcome. Linked a product and packaging launch with environmental fundraising for the Surfrider Foundation.
- 1997Emergen-C Fund
United States
Alacer created the Emergen-C Fund to support organizations working in areas including nutrition, environmental protection, cancer support, and global development. Reference material reports that the fund raised more than $650,000.
Outcome. Supported multiple nonprofit organizations, including Vitamin Angels, the Surfrider Foundation, Keep A Breast Foundation, the Young Survival Coalition, and Whole Planet Foundation.
- Operation Gratitude sponsorship
United States
Alacer sponsored Operation Gratitude, a volunteer organization known for sending care packages to U.S. troops serving in Iraq and Afghanistan.
Outcome. Provided corporate support for Operation Gratitude's care-package activities.
Brand decisions
2022
Transfer to HaleonM&ABackground
The consumer-health business associated with GSK was separated into Haleon.
Action taken
Emergen-C became owned by Haleon on 18 July 2022.
Aftermath
The brand continued as part of Haleon's international consumer-health portfolio.
2019
Entry into Pfizer-GSK consumer-health joint ventureM&ABackground
Pfizer reorganized its consumer-health interests through a joint venture with GSK.
Action taken
Pfizer's consumer-health business entered a joint venture with GSK.
Aftermath
Emergen-C later became part of Haleon following the separation of the consumer-health business from GSK.
2012
Pfizer acquisition of AlacerM&ABackground
Alacer's acquisition moved Emergen-C from an independent supplement company into Pfizer's consumer-health operations.
Action taken
Pfizer acquired Alacer Corp.
Aftermath
Emergen-C became part of a multinational consumer-health portfolio that later moved through the Pfizer-GSK consumer-health joint venture and into Haleon.
2012
Planned relocation of powdered supplement productionStrategyBackground
Plans to close a GSK manufacturing plant in Carlisle, Pennsylvania affected production of Emergen-C powdered drink mixes.
Action taken
Production was planned to shift from Carlisle to a facility in Puerto Rico.
Aftermath
The plan indicated a change in the brand's manufacturing footprint and supply-chain structure.
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/emergen-c · Editorial policy · How profiles are compiled